Drs Sparks and Bansal discuss the screening and treatment for CKD as a primary care physician, including testing, cardiovascular risk, new treatments, and when to refer a patient to a nephrologist.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/971889). The topics and discussions are planned, produced, and reviewed independently of advertiser. This podcast is intended only for US healthcare professionals.

Resources

Estimated GFR Can Widely Diverge From Measured GFR https://www.medscape.com/viewarticle/976533

Kidney Failure Risk Equation Works Without Race Adjustment https://www.medscape.com/viewarticle/966313

The Kidney Failure Risk Equation https://kidneyfailurerisk.com/

Don't Routinely Stop RAS Inhibitors in Advanced Kidney Disease https://www.medscape.com/viewarticle/943717

What Is the Role of Mineralocorticoid Receptor Antagonists (MRAs) in the Treatment of Proteinuria? https://www.medscape.com/answers/238158-93529/what-is-the-role-of-mineralocorticoid-receptor-antagonists-mras-in-the-treatment-of-proteinuria

What Is the Role of SGLT2 Inhibitors in the Treatment of Chronic Kidney Disease (CKD)? https://www.medscape.com/answers/238798-105205/what-is-the-role-of-sglt2-inhibitors-in-the-treatment-of-chronic-kidney-disease-ckd

Sodium-Glucose Cotransporter 2 Inhibitors: Safety Concerns https://www.medscape.com/viewarticle/892957_6

finerenone (Rx) https://reference.medscape.com/drug/kerendia-finerenone-4000168

Cardiovascular Disease in Chronic Kidney Disease https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.050686